Journal article · 2025
The dawn of ‘off-the-shelf’ B cell-depleting therapies for autoimmune diseases
Nature Reviews Rheumatology, 22(2), 78–79 · Published 10 December 2025 · DOI 10.1038/s41584-025-01343-5
In brief
“The dawn of ‘off-the-shelf’ B cell-depleting therapies for autoimmune diseases” is a 2025 journal article by Huji Xu, published in Nature Reviews Rheumatology. OpenAlex counts 6 citations as of 20 November 2026, which puts it in the top 3% of works published in 2025 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 6
- Most cited in
- 2026 (6)
- Field-weighted impact
- 1.63
- References
- 9
- Authors
- 1
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Xu, H. (2025). The dawn of ‘off-the-shelf’ B cell-depleting therapies for autoimmune diseases. Nature Reviews Rheumatology, 22(2), 78–79. https://doi.org/10.1038/s41584-025-01343-5
MLA 9
Xu, Huji. “The dawn of ‘off-the-shelf’ B cell-depleting therapies for autoimmune diseases.” Nature Reviews Rheumatology, vol. 22, no. 2, 2025, pp. 78–79. https://doi.org/10.1038/s41584-025-01343-5.
Chicago
Xu, Huji. 2025. “The dawn of ‘off-the-shelf’ B cell-depleting therapies for autoimmune diseases.” Nature Reviews Rheumatology 22 (2): 78–79. https://doi.org/10.1038/s41584-025-01343-5.
Harvard
Xu, H. (2025) ‘The dawn of ‘off-the-shelf’ B cell-depleting therapies for autoimmune diseases’, Nature Reviews Rheumatology, 22(2), pp. 78–79. doi:10.1038/s41584-025-01343-5.
IEEE
H. Xu, “The dawn of ‘off-the-shelf’ B cell-depleting therapies for autoimmune diseases,” Nature Reviews Rheumatology, vol. 22, no. 2, pp. 78–79, 2025, doi: 10.1038/s41584-025-01343-5.
BibTeX
@article{xu2025dawn,
title = {{The dawn of ‘off-the-shelf’ B cell-depleting therapies for autoimmune diseases}},
author = {Xu, Huji},
journal = {Nature Reviews Rheumatology},
year = {2025},
volume = {22},
number = {2},
pages = {78--79},
doi = {10.1038/s41584-025-01343-5},
url = {https://doi.org/10.1038/s41584-025-01343-5}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- B-cell depletion
- off-the-shelf therapy
- autoimmune disease
- chimeric antigen receptor
- bispecific antibodies
- B-cell depletion therapy
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Xu, H. (2025). The dawn of ‘off-the-shelf’ B cell-depleting therapies for autoimmune diseases. Nature Reviews Rheumatology, 22(2), 78–79. https://doi.org/10.1038/s41584-025-01343-5
How many times has this paper been cited?
6 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Huji Xu.
What is the DOI of this paper?
10.1038/s41584-025-01343-5, permanently at https://doi.org/10.1038/s41584-025-01343-5. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.